On the pharmacogenetics of non-small cell lung cancer treatment.
about
Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLCHistorical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer.Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1.5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer.
P2860
On the pharmacogenetics of non-small cell lung cancer treatment.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
On the pharmacogenetics of non-small cell lung cancer treatment.
@en
type
label
On the pharmacogenetics of non-small cell lung cancer treatment.
@en
prefLabel
On the pharmacogenetics of non-small cell lung cancer treatment.
@en
P2093
P2860
P1476
On the pharmacogenetics of non-small cell lung cancer treatment.
@en
P2093
Christian Rolfo
G J Peters
Leticia G Leon
Mariacarmela Santarpia
P2860
P304
P356
10.1517/17425255.2016.1141894
P407
P577
2016-01-13T00:00:00Z